— Know what they know.
Not Investment Advice
Also trades as: HLN (NYSE) · $vol 136M · HLN.L (LSE) · $vol 124M

HLNCF Earnings

Haleon plc
1W: -3.5% 1M: +10.8% 3M: -0.8% YTD: +4.6% 1Y: +8.0% 3Y: +34.3%
$5.00
-0.10 (-1.86%)
Pre-Market: $5.02 (+0.01, +0.20%)
Weekly Expected Move ±6.0%
$4 $5 $5 $5 $6
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Buy · Power 78 · $44.0B mcap · 8.40B float · 0.0001% daily turnover · Short 72% of daily vol
Credit Risk of going bust: lower than 82% of companies Debt: 19.8% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.08 (down 98%), Haleon plc would be worth roughly what it owes.
Total debt $10.92B against a stock market value of $44.33B.
Distance to default 10.04 (Merton model): prices to 2026-10-27, balance sheet 2025-12-31, debt counted $6.68B (short-term plus half of long-term), stock volatility 23.4%; Altman Z'' 3.98. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Last Earnings 2026-07-30
EPS
£0.14 (US$0.18)
▲ Beat +2.9%
Revenue
£7.4B ($9.9B)
▲ Beat +0.2%
EPS Beat Streak: 2 quarters
Next Earnings Qtr ending 2026-12-30 · date TBD
EPS Estimate
£0.04 (US$0.05)
Range: £0.04 - £0.04
Revenue Estimate
£2.4B ($3.2B)
1 analysts
1 USD = 0.75 GBP

Estimate vs Actual

Earnings Surprise History

4/18
EPS Beats
5/18
Revenue Beats
22%
EPS Beat Rate
28%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-26 annual 2030-12-31 £0.26 £0.26 — £13,172,523,703 £13,156,781,218
2026-10-26 annual 2027-12-31 £0.23 £0.23 — £12,038,904,858 £12,024,517,162
2026-10-26 annual 2028-12-31 £0.25 £0.25 — £12,525,920,039 £12,510,950,311
2026-10-26 annual 2026-12-31 £0.21 £0.21 — £11,556,648,984 £11,542,837,632
2026-10-26 quarter 2029-03-30 £0.11 £0.11 — £5,871,797,419 £5,864,780,033
2026-10-26 annual 2029-12-31 £0.26 £0.26 — £12,930,581,495 £12,915,128,156
2026-10-23 quarter 2029-03-30 £0.11 £0.11 — £5,865,657,207 £5,871,797,419
2026-10-23 annual 2026-12-31 £0.21 £0.21 — £11,544,564,051 £11,556,648,984
2026-10-23 annual 2027-12-31 £0.23 £0.23 — £12,026,315,624 £12,038,904,858
2026-10-23 annual 2028-12-31 £0.25 £0.25 — £12,512,821,527 £12,525,920,039
2026-10-23 annual 2029-12-31 £0.26 £0.26 — £12,917,059,823 £12,930,581,495
2026-10-23 annual 2030-12-31 £0.26 £0.26 — £13,158,749,029 £13,172,523,703
2026-10-22 annual 2027-12-31 £0.23 £0.23 — £11,963,369,453 £12,026,315,624
2026-10-22 quarter 2029-03-30 £0.11 £0.11 — £5,834,956,145 £5,865,657,207
2026-10-22 annual 2026-12-31 £0.21 £0.21 — £11,484,139,385 £11,544,564,051
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms